Search results for “Silicified microcrystalline cellulose” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 226 patents, we discovered top 93 key players by total patent application. Adare Pharmaceuticals, Inc., Lek Pharmaceuticals dd, J. Rettenmaier & Söhne GmbH + Co. KG are dominant in this area. They take 20.80% of the total patent filing.
Adare Pharmaceuticals, Inc.
New Jersey, United States
Patent: 16
Lek Pharmaceuticals dd
Ljubljana, Slovenia
Patent: 16
J. Rettenmaier & Söhne GmbH + Co. KG
Baden-Württemberg, Germany
Patent: 15
Neurocrine Biosciences, Inc.
California, United States
Patent: 12
Schering Oy
Finland
Patent: 12
Synthon BV
Gelderland, Netherlands
Patent: 10
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 6
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 6
Schering Corp.
New Jersey, United States
Patent: 5
Alara Pharmaceutical Corp.
Puerto Rico
Patent: 5
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 68 patents applied in the last 5 years. We discover 43 most active companies in this area. The fast-growing Neurocrine Biosciences, Inc., Takeda Pharmaceutical Co., Ltd., Venturepharma, Inc. take 30.88% of patent filing during this period.
Neurocrine Biosciences, Inc.
California, United States
Patent: 12
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 6
Venturepharma, Inc.
Beijing Shi, China
Patent: 3
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
China
Patent: 3
AgeneBio, Inc.
Indiana, United States
Patent: 3
BeiGene (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Jiangsu Xidian Pharmaceutical Excipients Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Anqing Chengfeng Pharmaceutical Co. Ltd.
Anhui Sheng, China
Patent: 1
Hangzhou Muyuan Biomedical Technology Co., Ltd.
China
Patent: 1
China Resources Double-Crane Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 68 patents in last 5 years, we discover 40 new entrants. Neurocrine Biosciences, Inc., Takeda Pharmaceutical Co., Ltd., Venturepharma, Inc. are the most active new entrants in this area.
Neurocrine Biosciences, Inc.
California, United States
Patent: 12
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 6
Venturepharma, Inc.
Beijing Shi, China
Patent: 3
Hangzhou Bio-Sincerity Pharma-Tech Co., Ltd.
China
Patent: 3
BeiGene (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 3
Jiangsu Xidian Pharmaceutical Excipients Co., Ltd.
Jiangsu Sheng, China
Patent: 2
Anqing Chengfeng Pharmaceutical Co. Ltd.
Anhui Sheng, China
Patent: 1
Hangzhou Muyuan Biomedical Technology Co., Ltd.
China
Patent: 1
China Resources Double-Crane Pharmaceutical Co., Ltd.
Beijing Shi, China
Patent: 1
Shanghai Yuyao Biomedicine Technology Co., Ltd
China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Warszawski Uniwersytet Medyczny
Mazowieckie, Poland
Patent: 1
Wuhan Polytechnic University
Hubei Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: